Serum CR‐1 levels in NSCLC patients were higher than those of healthy controls (4.13 ± 1.38 ng/ml vs. 1.03 ± 0.36 ng/ml, p < 0.05, Figure 1A, Table 1). This evidence concerns the gene CR1 and non-small cell lung carcinoma.